Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 17, 2024 Filed Jan 29, 2024 17:06 UTC |
SANTOS HELENA RDirector · CEO and President
|
PurchaseCommon Stock | 11 | $2.00 | $22.00 |
DisclosureSEC source: 0001182944-24-000002 · primary_doc.xml · nonDerivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,288 F1 · balance_after: Includes 1,977 warrants inclusive of 11 warrants acquired in this transaction plus 232,366 stock options. Read SEC document |
| December 20, 2023 Filed Dec 28, 2023 21:51 UTC |
SCHUMACHER JURGEN WALTERDirector
|
GrantWarrants · Derivative | 67,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001987646-23-000003 · primary_doc.xml · derivative · entry 1 SCHUMACHER JURGEN WALTER · CIK 0001987646 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Shareholder Disclosed balance after: 80,131 Underlying: Commons Stock · 67,500 shares Expires 2028-12-20 F1 · ownership.nature: Reporting person is a shareholder of owner of securities. Read SEC document |
| December 20, 2023 Filed Dec 28, 2023 21:42 UTC |
SCHUMACHER JURGEN WALTERDirector
|
GrantCommon Stock | 67,500 | $2.00 | $135,000.00 |
DisclosureSEC source: 0001987646-23-000002 · primary_doc.xml · nonDerivative · entry 1 SCHUMACHER JURGEN WALTER · CIK 0001987646 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Shareholder Disclosed balance after: 80,131 F1 · ownership.nature: Reporting person is a shareholder of the owner of the securities. Read SEC document |
| December 20, 2023 Filed Jan 29, 2024 17:39 UTC |
MOORE JOHN ADirector
|
PurchaseWarrants to Purchase Common Stock · Derivative | 2,030 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001182944-24-000005 · primary_doc.xml · derivative · entry 2 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,508 Underlying: Common Stock · 2,030 shares Expires 2028-12-20 F2 · balance_after: Includes 65,556 warrants inclusive of 2,030 acquired herewith plus 227,952 stock options. Read SEC document |
| December 20, 2023 Filed Jan 29, 2024 17:39 UTC |
MOORE JOHN ADirector
|
PurchaseCommon stock | 2,030 | $2.00 | $4,060.00 |
DisclosureSEC source: 0001182944-24-000005 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,290 F1 · balance_after: Includes 65,556 warrants inclusive of 2,030 acquired herewith plus 227,952 stock options Read SEC document |
| December 19, 2023 Filed Jan 29, 2024 17:28 UTC |
MOORE JOHN ADirector
|
PurchaseWarrants to Purchase Common Stock · Derivative | 20,400 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001182944-24-000004 · primary_doc.xml · derivative · entry 2 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,478 Underlying: Common Stock · 20,400 shares Expires 2028-12-19 F2 · balance_after: Includes 63,526 warrants inclusive of 20,400 acquired herewith and 227,952 stock otpions. Read SEC document |
| December 19, 2023 Filed Jan 29, 2024 17:28 UTC |
MOORE JOHN ADirector
|
PurchaseCommon Stock | 20,400 | $2.00 | $40,800.00 |
DisclosureSEC source: 0001182944-24-000004 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 394,230 F1 · balance_after: Includes 63,526 warrants inclusive of 20,400 acquired herewith and 227,952 stock options. Read SEC document |
| December 19, 2023 Filed Jun 28, 2024 21:13 UTC |
Cox Christopher TDirector
|
PurchaseWarrants to Purchase Common Stock · Derivative | 79,245 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001557341-24-000003 · primary_doc.xml · derivative · entry 2 Cox Christopher T · CIK 0001557341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,245 Underlying: Common Stock · 79,245 shares Expires 2028-12-19 Read SEC document |
| December 19, 2023 Filed Jun 28, 2024 21:13 UTC |
Cox Christopher TDirector
|
PurchaseCommon Stock | 79,245 | $2.00 | $158,490.00 |
DisclosureSEC source: 0001557341-24-000003 · primary_doc.xml · nonDerivative · entry 1 Cox Christopher T · CIK 0001557341 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,245 Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:39 UTC |
Bleichroeder LP10% owner
|
PurchaseWarrants to Purchase Common Stock · Derivative | 960,000 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001781002-23-000050 · primary_doc.xml · derivative · entry 6 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 960,000 Underlying: Common Stock · 960,000 shares Expires 2028-12-13 F1 · kind: On December 13, 2023, 21 April Fund, Ltd., 21 April Fund, LP and Scientific Industries Inc. (the "Issuer") entered into an agreement (the "Securities Purchase Agreement") under which 21 April Fund, Ltd. and 21 April Fund, LP purchased from the Issuer, for an aggregate purchase price of $1,200,000, 600,000 shares of Common Stock and warrants to acquire 960,000 shares of Common Stock at an exercise price of $2.50 per share. F1 · price: On December 13, 2023, 21 April Fund, Ltd., 21 April Fund, LP and Scientific Industries Inc. (the "Issuer") entered into an agreement (the "Securities Purchase Agreement") under which 21 April Fund, Ltd. and 21 April Fund, LP purchased from the Issuer, for an aggregate purchase price of $1,200,000, 600,000 shares of Common Stock and warrants to acquire 960,000 shares of Common Stock at an exercise price of $2.50 per share. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:39 UTC |
Bleichroeder LP10% owner
|
OtherWarrants to Purchase Common Stock · Derivative | 22,728 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001781002-23-000050 · primary_doc.xml · derivative · entry 5 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 22,728 Underlying: Common Stock · 22,728 shares Expires 2028-12-13 F3 · kind: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F3 · price: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:39 UTC |
Bleichroeder LP10% owner
|
OtherWarrants to Purchase Common Stock · Derivative | 22,728 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001781002-23-000050 · primary_doc.xml · derivative · entry 4 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 22,728 shares Expires 2027-03-02 F3 · kind: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F3 · price: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:39 UTC |
Bleichroeder LP10% owner
|
OtherWarrants to Purchase Common Stock · Derivative | 278,947 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001781002-23-000050 · primary_doc.xml · derivative · entry 3 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 278,947 Underlying: Common Stock · 278,947 shares Expires 2028-12-13 F3 · kind: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F3 · price: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:39 UTC |
Bleichroeder LP10% owner
|
OtherWarrants to Purchase Common Stock · Derivative | 278,947 | Not disclosed Strike: $9.50 | Not disclosed |
DisclosureSEC source: 0001781002-23-000050 · primary_doc.xml · derivative · entry 2 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 278,947 shares Expires 2026-06-18 F3 · kind: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F3 · price: On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 21:39 UTC |
Bleichroeder LP10% owner
|
PurchaseCommon Stock | 600,000 | $2.00 | $1,200,000.00 |
DisclosureSEC source: 0001781002-23-000050 · primary_doc.xml · nonDerivative · entry 1 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,203,351 F1 · price: On December 13, 2023, 21 April Fund, Ltd., 21 April Fund, LP and Scientific Industries Inc. (the "Issuer") entered into an agreement (the "Securities Purchase Agreement") under which 21 April Fund, Ltd. and 21 April Fund, LP purchased from the Issuer, for an aggregate purchase price of $1,200,000, 600,000 shares of Common Stock and warrants to acquire 960,000 shares of Common Stock at an exercise price of $2.50 per share. F2 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 13, 2023 Filed Dec 29, 2023 17:01 UTC |
SANTOS HELENA RDirector · President
|
GrantWarrants · Derivative | 1,250 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001286205-23-000002 · primary_doc.xml · derivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,266 Underlying: Commons Stock · 1,250 shares Expires 2028-12-13 Read SEC document |
| December 13, 2023 Filed Dec 29, 2023 16:50 UTC |
SANTOS HELENA RDirector · President
|
GrantCommon Stock | 1,250 | $2.00 | $2,500.00 |
DisclosureSEC source: 0001286205-23-000001 · primary_doc.xml · nonDerivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,016 Read SEC document |
| December 13, 2023 Filed Jan 17, 2024 21:48 UTC |
Frampton Marcus10% owner
|
PurchaseWarrants to Purchase Common Stock · Derivative | 27,530 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001776356-24-000001 · primary_doc.xml · derivative · entry 2 Frampton Marcus · CIK 0001776356 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,030 Underlying: Common Stock · 27,530 shares Expires 2028-12-13 Read SEC document |
| December 13, 2023 Filed Jan 17, 2024 21:48 UTC |
Frampton Marcus10% owner
|
PurchaseCommon Stock | 27,530 | $2.00 | $55,060.00 |
DisclosureSEC source: 0001776356-24-000001 · primary_doc.xml · nonDerivative · entry 1 Frampton Marcus · CIK 0001776356 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,683 F1 · balance_after: Includes 31,030 warrants inclusive of 27,530 warrants acquired in this transaction. Read SEC document |
| December 13, 2023 Filed Jan 29, 2024 17:16 UTC |
MOORE JOHN ADirector
|
PurchaseWarrants to Purchase Common Stock · Derivative | 26,100 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001182944-24-000003 · primary_doc.xml · derivative · entry 2 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,078 Underlying: Common Stock · 26,100 shares Expires 2028-12-13 F2 · balance_after: Includes 43,126 warrants inclusive of 26,100 acquired herewith plus 227,952 stock options. Read SEC document |
| December 13, 2023 Filed Jan 29, 2024 17:16 UTC |
MOORE JOHN ADirector
|
PurchaseCommon stock | 26,100 | $2.00 | $52,200.00 |
DisclosureSEC source: 0001182944-24-000003 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,430 F1 · balance_after: Includes 43,126 warrants inclusive of 26,100 warrants acquired herewith and 227,952 stock options. Read SEC document |
| December 13, 2023 Filed Jul 31, 2024 20:55 UTC |
NICOLS JOHN JDirector
|
PurchaseWarrant to Purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001238884-24-000003 · primary_doc.xml · derivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 15,000 shares Expires 2028-12-13 Read SEC document |
| December 13, 2023 Filed Jul 31, 2024 20:55 UTC |
NICOLS JOHN JDirector
|
PurchaseCommon Stock | 15,000 | $2.00 | $30,000.00 |
DisclosureSEC source: 0001238884-24-000003 · primary_doc.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 21:02 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 4,000 | $5.18 | $20,720.00 |
DisclosureSEC source: 0001267216-22-000009 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,062 Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 20:56 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 3,600 | $5.18 | $18,648.00 |
DisclosureSEC source: 0001267216-22-000008 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 120,062 Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 17:28 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 400 | $5.10 | $2,040.00 |
DisclosureSEC source: 0001267216-22-000007 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,662 Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 19:38 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 1,000 | $5.00 | $5,000.00 |
DisclosureSEC source: 0001267216-22-000006 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 124,062 Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 19:35 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 1,000 | $5.00 | $5,000.00 |
DisclosureSEC source: 0001267216-22-000005 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,062 Read SEC document |
| May 23, 2022 Filed May 24, 2022 18:43 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 1,000 | $5.00 | $5,000.00 |
DisclosureSEC source: 0001267216-22-000004 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 126,062 Read SEC document |
| May 23, 2022 Filed May 24, 2022 18:34 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 1,000 | $5.00 | $5,000.00 |
DisclosureSEC source: 0001267216-22-000003 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,062 Read SEC document |
| May 19, 2022 Filed May 20, 2022 20:31 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 740 | $5.00 | $3,700.00 |
DisclosureSEC source: 0001267216-22-000002 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,062 Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 15:35 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 2,840 | $6.05 | $17,182.00 |
DisclosureSEC source: 0001267216-22-000001 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,802 Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 16:59 UTC |
Bleichroeder LP10% owner
|
PurchaseWarrants · Derivative | 22,728 | $5.50 Strike: $5.50 | $125,004.00 |
DisclosureSEC source: 0001781002-22-000027 · primary_doc.xml · derivative · entry 2 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 301,675 Underlying: Common Stock · 22,728 shares Expires 2027-03-02 F2 · derivative.exercise_price: On March 2, 2022, 21 April Fund, Ltd., 21 April Fund, LP and SCIENTIFIC INDUSTRIES, INC. (the "Issuer") entered into an agreement (the "Purchase Agreement") under which 21 April Fund, Ltd. and 21 April Fund, LP purchased from the Issuer warrants (the Warrants) to purchase up to 22,728 additional shares of common stock, at a per share exercise price of $5.50. The Warrants are exercisable in whole or in part at any time prior to the fifth anniversary of the issuance date. F1 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 16:59 UTC |
Bleichroeder LP10% owner
|
PurchaseCommon Stock | 45,456 | $5.50 | $250,008.00 |
DisclosureSEC source: 0001781002-22-000027 · primary_doc.xml · nonDerivative · entry 1 Bleichroeder LP · CIK 0001781002 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 603,351 F1 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 02, 2022 Filed Mar 15, 2022 19:58 UTC |
SANTOS HELENA RDirector · President and CEO
|
PurchaseWarrants to Purchase Common Stock · Derivative | 190 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001286205-22-000001 · primary_doc.xml · derivative · entry 2 SANTOS HELENA R · CIK 0001286205 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,766 Underlying: Common Stock · 190 shares Expires 2027-03-02 Read SEC document |
| March 02, 2022 Filed Mar 15, 2022 19:58 UTC |
SANTOS HELENA RDirector · President and CEO
|
PurchaseCommon Stock | 380 | $5.50 | $2,090.00 |
DisclosureSEC source: 0001286205-22-000001 · primary_doc.xml · nonDerivative · entry 1 SANTOS HELENA R · CIK 0001286205 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,576 Read SEC document |
| March 02, 2022 Filed Mar 15, 2022 19:50 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseWarrants to Purchase Common Stock · Derivative | 6,500 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001182944-22-000001 · primary_doc.xml · derivative · entry 2 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,230 Underlying: Common Stock · 6,500 shares Expires 2027-03-02 Read SEC document |
| March 02, 2022 Filed Mar 15, 2022 19:50 UTC |
MOORE JOHN ADirector · Chairman of the Board
|
PurchaseCommon Stock | 13,000 | $5.50 | $71,500.00 |
DisclosureSEC source: 0001182944-22-000001 · primary_doc.xml · nonDerivative · entry 1 MOORE JOHN A · CIK 0001182944 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,730 Read SEC document |
| March 02, 2022 Filed Mar 30, 2022 01:01 UTC |
Frampton MarcusDirector
|
PurchaseWarrants to Purchase Common Stock · Derivative | 3,500 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001776356-22-000001 · primary_doc.xml · derivative · entry 2 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,500 shares Expires 2027-03-02 Read SEC document |
| March 02, 2022 Filed Mar 30, 2022 01:01 UTC |
Frampton MarcusDirector
|
PurchaseCommon Stock | 7,000 | $5.50 | $38,500.00 |
DisclosureSEC source: 0001776356-22-000001 · primary_doc.xml · nonDerivative · entry 1 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,313 F1 · balance_after: Additionally, Mr. Frampton controls 59,810 that are held by Falcon Juneau, LLC, an investment partnership that he owns less than 50% of. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 18:30 UTC |
CREMONESE JOSEPH GDirector
|
SaleCommon Stock | 2,770 | $6.50 | $18,005.00 |
DisclosureSEC source: 0001267216-21-000001 · primary_doc.xml · nonDerivative · entry 1 CREMONESE JOSEPH G · CIK 0001267216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,642 Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 11:32 UTC |
Frampton MarcusDirector
|
PurchaseCommon Stock | 800 | $5.71 | $4,568.00 |
DisclosureSEC source: 0001776356-21-000004 · primary_doc.xml · nonDerivative · entry 4 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,313 Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 11:32 UTC |
Frampton MarcusDirector
|
SaleCommon Stock | 1,900 | $5.60 | $10,640.00 |
DisclosureSEC source: 0001776356-21-000004 · primary_doc.xml · nonDerivative · entry 3 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 59,810 Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 11:32 UTC |
Frampton MarcusDirector
|
PurchaseCommon Stock | 1,000 | $5.68 | $5,680.00 |
DisclosureSEC source: 0001776356-21-000004 · primary_doc.xml · nonDerivative · entry 2 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,513 Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 11:32 UTC |
Frampton MarcusDirector
|
SaleCommon Stock | 2,000 | $5.46 | $10,920.00 |
DisclosureSEC source: 0001776356-21-000004 · primary_doc.xml · nonDerivative · entry 1 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 61,710 Read SEC document |
| December 01, 2021 Filed Dec 20, 2021 15:07 UTC |
NICHOLS ROBERTSecretary
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $5.85 | $0.00 |
DisclosureSEC source: 0001422596-21-000001 · primary_doc.xml · derivative · entry 1 NICHOLS ROBERT · CIK 0001422596 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,241 Underlying: Common Stock · 10,000 shares Expires 2031-12-01 F1 · derivative.exercise_date: Exercisable as to 1/3 on each of the first, second, and third anniversaries of date of grant. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 20:28 UTC |
Frampton MarcusDirector
|
PurchaseCommon Stock | 378 | $5.77 | $2,181.06 |
DisclosureSEC source: 0001776356-21-000003 · primary_doc.xml · nonDerivative · entry 2 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,513 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 20:28 UTC |
Frampton MarcusDirector
|
SaleCommon Stock | 1,050 | $5.64 | $5,922.00 |
DisclosureSEC source: 0001776356-21-000003 · primary_doc.xml · nonDerivative · entry 1 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 63,710 Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 01:19 UTC |
Frampton MarcusDirector
|
PurchaseCommon Stock | 500 | $10.73 | $5,365.00 |
DisclosureSEC source: 0001776356-21-000001 · primary_doc.xml · nonDerivative · entry 2 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,135 Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 01:19 UTC |
Frampton MarcusDirector
|
SaleCommon Stock | 3,100 | $10.58 | $32,798.00 |
DisclosureSEC source: 0001776356-21-000001 · primary_doc.xml · nonDerivative · entry 1 Frampton Marcus · CIK 0001776356 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares held in Falcon Juneau, LLC an investment partnership controlled by Marcus Frampton Disclosed balance after: 64,760 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.